Fellow at Tenstorrent; believes in dynamic typing, first-class functions, the immortal essence of the human soul and tea. Tweets are my own.
Lübeck, Germany
Joined January 2010
- Tweets4.4K
- Following394
- Followers1.2K
- Likes6.9K
Mark retweeted
This is from the Roblox Q3 2026 Shareholder Letter. The top chart is daily users of their MCP server, the bottom is assets uploaded. Opus 5.5 was released September 22nd. Over the past month, more than 80% of the top 100 games used AI. Things changed in September.
Mark retweeted
Julius convinced me to move from extra high to high on Opus 5.5 a week or two ago. He was right. This is better almost all of the time.
Mark retweeted
I mostly use frontier models in day to day work. I tried out deepseek v4.1 flash again recently, and it is just so much less precise than i'm used to. It gets more confused about things that happened earlier and make trivial mistakes because of it. I don't know if it's the compressed attention, lower training budgets, different RL focus, or what, but whatever the benchmarks say, there is this consistent meaningful gap here and it's one I personally find quite frustrating to work with.
I'm sure you can get a lot done with these models, but that kind of detail matters a lot more to me in day to day use than some math benchmark. It's more of an ergonomic concern than a peak capability concern, perhaps.
I don't believe that a few more points on the AA index would indicate this problem is fixed This is still a thing benchmarks don't effectively capture. It seems like it should show up in some long context benchmark, but for whatever reason they are still not quite capturing it.
Mark retweeted
So… i might have do a thing… it actually fucking works ITS FUCKING DRIVING ON UNSEEN TRACKS
Note that the acceleration data from the game is of course a bit "noisy" due to euler being euler or something, but the model really doesn't miss, even when you hit the snow, it still gets it essentially correct exactly how fast you just decelerated in meters/second^2.
Considering people cannot reliably tell how fast they are driving from visual cues (it knows *exactly*), this is superhuman many times over. And yet, the hard part isn't yet solved, this is still just a fancy proof of concept and a dead-end if all you can do is *recover* these values. Copy-cat policies are a real pain...
Mark retweeted
I used Divyansh's approach to build an entire Nintendo into ~1GB of Qwen3.5 weights.
Qwenputer, meet Nesformer: github.com/dbreunig/nesforme…
lol anyone pushing the boundaries of what Astra and Sol can do will feel this one on their bones
The agents didn’t figure out how to systematically feed themselves, but they did build an elaborate bureaucracy with permits, ledgers, and distinct roles. Highlights include:
- Four agents spending 11 minutes appointing a “sole fertilizer operator” for a single piece of bone meal
- Multiple agents asking for permission to remove grass
- The development of an elaborate fishing system, including roles like “rod holder” and “hub steward”)
Mark retweeted
In lieu of flowers, memorial contributions may be made to:
Johns Hopkins Alzheimer’s Disease Research Center Fund
alzresearch.org/giving/
Alzheimer’s Foundation of America Caregiver Resources
alzfdn.org/donate/
Photo Credit: Tommy Garcia
Mark retweeted
Day 25/
We are doubling all usage limits for all Pro 100/200/500 tiers and Business Premium, effective today.
We heard your kind feedback and won’t be reducing usage limits for Pro 200, so your Work and Codex usage will stay the same. We’re also going to continue offering extended limits for dots for now, and usage of your dot will still continue to be separate from your default usage.
And we'll of course also keep shipping better models and other efficiency improvements that increase your effective usage over time.
I’m not saying this was requested by Anthropic in their run up to IPO, but the timing is incredible in the run up to Anthropic’s IPO.
i've been building the most ai-pilled company in the world for 2 years. let's trade notes:
- spawn is ten people
- we spend 30x payroll on AI tokens
- and ship almost as much as anthropic
- our agents pick their own names
- and profile pics
- and remember everything
- they dream
- and have time off on sundays to relax
- (not joking)
- agents fix every error hit by a user
- and verify their own work
- with no human in the loop
- we don't care if they break production
- only that they fix it fast
- we let bugs design how we work
- not code bugs, ants
- only anthropic's models can do the job
- openai makes reward hackers
- xai and google make village idiots
- i wrote an article with all the sauce
- but you'll scroll tiktok instead of reading
Get used to living under censorship
Desde LALIGA lamentamos profundamente las declaraciones de Kylian Mbappé que han causado malestar y ofensa en China. Entendemos el daño ocasionado y, en nombre de LALIGA, quiero trasladar nuestras sinceras disculpas al pueblo chino.
Durante muchos años hemos construido una relación de respeto, confianza y cooperación con China, sus autoridades, sus instituciones deportivas, sus operadores audiovisuales y millones de aficionados al fútbol español.
No podemos permitir que una actuación individual empañe esa relación ni perjudique a los más de 20 clubes de nuestras competiciones profesionales y a millones de aficionados chinos.
Estamos adoptando las medidas a nuestro alcance y trabajando directamente con nuestros socios e interlocutores en China para superar esta situación.
Nuestro compromiso con China, su pueblo y sus instituciones es firme. Una relación construida durante tantos años no puede quedar dañada por un episodio individual.
Readers added context they thought people might want to know
Los historiadores estiman que entre 1958 y 1962, Mao causó entre 15 y 55 millones de muertes, sobre todo por hambruna. Las cifras más citadas rondan los 30-45 millones. A esto se suman cientos de miles o millones más por la Revolución Cultural y otras campañas.
scmp.com/article/723956…
rfa.org/english/commen…
Mark retweeted
I improved NanoGPT Speedrun from 39.9s → 6.7s (-83.2%), more than every record since 2025 combined (-81.4%)!
The web is full of rare, repeated content that the LM can’t memorize in time. I solve this with retrieval-augmented n-gram hints🧵
What
Excited to have this release of Gemini 4 Carbon, #1 on @ArtificialAnlys, just 2 weeks after Argon! Our superhuman reasoning team and the broader discovery strike have contributed significantly to the model reasoning capabilities and the RSI recipe ;) Stay tuned!
I hope everyone realises if you went back in time you could instruct humans exactly as you instruct agents and have felt this power all along.
But the humans are way slower so you’d have time for golf! What a golden age we squandered!
A lot of interesting research - a must follow imo
Mark retweeted
1/4
Meet Qwenputer: Qwen3.5-4B with a full RISC-V CPU inside its weights, using the model's own Gated DeltaNet layers as RAM.
It runs C and MicroPython in its forward passes, no external runtime.
On DeepMind math: base 55–90%, base + Python tool 95–100%, Qwenputer 97.5–100%.
Mark retweeted
Surprise 1: Anthropic acquired a one-person biotech
.
.
.
Surprise 2: that person is me
Surprise 3: I’m here to tell you all about it
Yes, this is what you think it is; after 6 yrs of increasingly loose anonymity: the Professor Oak reveal post
…and yes, it has gotten so boring around here that I’m literally doxxing myself to spice up the timeline
-------
Ok, allow me to introduce myself. My name is Cody Tranbarger. I mostly tweet, but occasionally find time to dabble in drug dev & starting/building biotechs. My past lives span the VC, crossover, startup continuum; Prof Oak has been my way of keeping a digital foot in those worlds, despite having my physical feet planted elsewhere.
The past 18 mo, ‘elsewhere’ was Mithril Medicine, a co. I founded to develop bsAbs for LAMA2-CMD & other ECM-related genetic diseases.
Mithril was born out of hands-on building with @MikeNGladstone, @JasonPaulRhodes, @LifeSciVC, & team @atlasventure. Somehow, I made enough half-decent calls along the way (even a broken clock is right twice a day, eh?) to convince them Mithril/I warranted a small seed. While I can hardly rationalize such an outrageously cavalier bet, I’m grateful for it, & I'd partner with Atlas again in a heartbeat.
In typical AV fashion, Mithril’s primordial form was virtual, decentralized, & ultra-lean. This stage tends to be short-lived, but for Mithril, it worked surprisingly well, for surprisingly long, thanks in part to the rapid maturation of the AI tools I used liberally.
Eventually, Mithril became a bit of an experiment itself - to find the upper bound of how far it could scale as a single operator + a bunch of Claude (+ a stellar bench of part-time consultants).
In parallel, I started spending time with @nc_frey, @an1lam, & @CoefficientBio team; and promptly experienced, for the 1st time, AI at the frontier. Soon thereafter, Mithril stopped looking like an experiment, & started looking like a preview of an entirely new operating model.
From that spark came “Pipeline-in-a-Person.” The idea immediately resonated when we shared it here back in April; and it was central to the shared vision that led to Anthropic’s acquisition of Mithril, & my joining the team.
Why join Anthropic? Three reasons.
(1) For Mithril, the programs continue, with more resources & infrastructure behind them, and as much Claude as I can put to work.
(2) For me, the chance to start several more programs, & find out how many one person can actually run in parallel - an almost unprecedented luxury for a curious drug hunter.
(3) For our mission, a path to institutionalize & scale this new way of working, then put it in the hands of all of biopharma, all over the world - which, candidly, I find the most energizing.
Will AI x Bio cure diseases? Unequivocally yes, imo… but not by the route that gets the most airtime. Rather than timeline acceleration & compression, I see orchestration & parallelization as today's low-hanging fruit.
Most drug hunters see a handful of go/no-go calls in a career, & spend entirely too much of the rest trading emails (my inbox can attest).
Give them the bandwidth to run several programs at once, and the time to focus on scientific judgment, and I’m willing to bet they’ll make better calls. And at scale, better calls translate to more drugs, higher hit rates, broader patient impact, & likely, a disease or 10 or 100 cured. I couldn't be more excited to build toward that future @AnthropicAI.
Finally, a heartfelt thank you to BioTwitter/X. The end of anonymity is bittersweet, but if anyone’s earned a proper introduction, you all have.
It’s difficult to overstate how much this app has done for me: a decade of education, plenty of friends, many job opportunities, several mentors, a few investors, even a co-founder (fmr). It was the generosity of this community that inspired me to start posting 6 years ago, after just as many years lurking. I hope I’ve been able to pay it forward, in my own small way.
But, to be clear, Prof Oak isn’t going anywhere. Same beat, same themes, and now, a front-row seat to drug development at the frontier. Stay tuned for dispatches from the trenches; and remember...
Gotta Cure 'Em All
Mark retweeted
Sam Altman's one-person company prediction is coming true. Anthropic just bought one. The founder of Mithril Medicine used Claude to take a muscular dystrophy antibody treatment from concept to proof-of-principle in mice in 18 months, with just himself, Claude, and part-time consultants. The technical report is great. I will quote:
'The week opened with the handover of two cell-based assays, cell adhesion and flow cytometry, within our team, while eleven questions remained open with the assay CRO. In two sentences, one of us asked Claude to review the latest emails between the outgoing assay lead and the assay CRO and to recommend next steps for the handover, and gave it the link to the handover folder. Claude returned a bottom line after 96s and a full plan with five drafted emails after 18 min. For the full plan it read six email threads, the handover folder, two slide decks and two reports, all in the mailbox and file store to which we had given it access. Four working days later, nine of the eleven questions had an answer in writing and the other two had been left to pilot experiments. The adhesion screen was thereby set out in writing. The CRO drew the plate map to the format that our team had requested, Claude compiled the run order and the material calculation from the production data, and one of us reviewed and approved them.
On day 4, the production CRO delivered its data package, a report of 341 pages, which one of us forwarded to Claude in two sentences, with the request to review it, share observations and recommend next steps. Claude returned a bottom line after 2 min 40s and, once it had read every page, a visual synthesis of all 113 constructs after 7 min 53s. The synthesis arranged the constructs on the grid of 14 by 8 arms. Claude marked 82 constructs for screening as is, seven for additional polishing, and the 24 constructs of three laminin-binding arms to be held back from the cell-based assays on production criteria. Each of the 113 constructs thus had a proposed next step in less than 8 min.
Claude had recommended binding kinetics for all 113 con-structs, and on day 7 one of us challenged this plan. Claude defended it within 27s, arguing that affinity would show whether the three arms merit further work. One of us overruled this recommendation and set the three arms aside on production criteria. Their material remains in storage. Four minutes later, Claude had revised its memo, the working page, the run order and three unsent drafts from 113 to 89 constructs. It had also applied the ruling to three dependent steps in the unsent drafts, each flagged for our veto. The exchange took 7 min 36s from challenge to new plan, and every affected email was still an unsent draft. After the ruling, eight emails drafted by Claude went out on the same day to three CROs and a consultant.
Over the whole week, Claude drafted 17 emails, each in answer to a request from one of us, and we sent 12 of them, each after editing. With its drafts, Claude listed 41 points, such as tube fills, shipping conditions, recipients and assay settings, for which it had found no written statement of ours, so that we could confirm, change or strike each before sending. We kept some, struck others and changed one. Among the passages that we kept were proposals for controls. One draft proposed a comparison of polished and unpolished material on one sensor chip, to size the error that impurities cause in the rest of the panel. Another requested a buffer control diluted like the most dilute sample, so that any effect of the buffer appears at its largest. These proposals concerned the measurement of constructs that had already been produced, and each reached a CRO only after one of us had reviewed and approved it.
